Apollo Hospitals Enterprise Ltd Share Price
(APOLLOHOSP)
₹6408.85
as on 01:23PM, 20 Feb 2025
Apollo Hospitals Enterprise Ltd Performance
Day's Low
Day's High
₹6,384.25Day's Price Range₹6,469.4552 Week's Low
52 Week's High
₹5,693.252-Week Price Range₹7,545.35
| Returns % | |
| 1 Month Return | -5.28 % |
| 3 Month Return | -4.74 % |
| 1 Year Return | -4.98 % |
| Market Stats | |
| Previous Close | ₹6,422.65 |
| Open | ₹6,408.00 |
| Volume | 1.95L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹92,347.85Cr |
Apollo Hospitals Enterprise Ltd Key Statistics
P/E Ratio
70.49
PEG Ratio
1.95
Market Cap
₹92,347.85 Cr
P/B Ratio
11.85
EPS
63.77
Dividend Yield
0.25
Sector
Healthcare
ROE
13.81
Apollo Hospitals Enterprise Ltd Mutual Fund Holdings
Apollo Hospitals Enterprise Ltd Analyst Rating
based on 29 analysts
86.21%
Buy
10.34%
Hold
3.45%
Sell
Based on 29 analysts offering long term price targets for Apollo Hospitals Enterprise Ltd. An average target of ₹7831.14
Source: S&P Global Market Intelligence
Apollo Hospitals Enterprise Ltd Share analysis
Apollo Hospitals Enterprise Ltd price forecast by 29 analysts
Upside of21.93%
High
₹9036
Target
₹7831.14
Low
₹5700
Apollo Hospitals Enterprise Ltd target price ₹7831.14, a slight upside of 21.93% compared to current price of ₹6408.85. According to 29 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Apollo Hospitals Enterprise Ltd revenue growth forecast
Expected growth rate Q1, FY2027:57.32%
Forecast
Actual
Including amortisation and stock based compensations
Apollo Hospitals Enterprise Ltd EPS growth forecast
EPS estimate Q1, FY2027:174.32%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Apollo Hospitals Enterprise Ltd
Apollo Hospitals Emphasizes AI Innovations in Healthcare - 18 Feb, 2025
Apollo Hospitals' CEO discussed significant AI-driven advancements in healthcare, focusing on predictive analytics and real-time monitoring to enhance patient care and early disease detection.Apollo Hospitals Projects Growth Amid Challenges - 13 Feb, 2025
Apollo Hospitals anticipates mid-teen revenue growth through expansion and high-end specialties. Q3-FY25 EBITDA slightly missed estimates due to external factors. Long-term investment is recommended.Apollo Hospitals Reports Growth Amid Dividend Announcement - 12 Feb, 2025
Apollo Hospitals reported a 14% revenue increase and a 52% profit surge in Q3 FY25. Despite positive earnings, the stock faced pressure due to competition and sequential moderation. Nuvama maintains a bullish outlook with a target price of ₹8200, while the company announces a ₹9 interim dividend, boosting share prices ahead of the record date.Apollo Hospitals Faces Profit Booking Despite Strong Q3 - 11 Feb, 2025
Apollo Hospitals reported a 51.8% profit increase in Q3, but shares fell due to profit booking. The company plans to expand with three new facilities in FY26, anticipating quick breakeven and substantial revenue growth.Apollo Hospitals Reports Strong Q3 Performance and Dividend - 10 Feb, 2025
Apollo Hospitals Enterprise reported a 52% increase in Q3 FY25 profit to Rs 372 crore, with revenue at Rs 5,527 crore. The board declared an interim dividend of Rs 9 per share, rewarding shareholders amid strong financial performance.Apollo Hospitals Expected to Report Strong Q3 Earnings - 07 Feb, 2025
Apollo Hospitals is projected to see a 41.5% increase in net profit to Rs 347 crore in Q3, driven by improved occupancy and higher average revenue per occupied bed (ARPOBs). Total revenue is expected to grow by 15% to Rs 5,575 crore. Analysts anticipate reduced losses from Apollo 24/7 will further enhance earnings growth.Apollo Hospitals Welcomes Budget Boost for Healthcare - 01 Feb, 2025
Apollo Hospitals expresses optimism about the Union Budget's potential to elevate India's healthcare system, focusing on medical tourism, R&D, and the establishment of cancer centers. The government's initiatives are expected to benefit private hospitals significantly.Positive Outlook for Apollo Hospitals Amid Budget Talks - 31 Jan, 2025
Analysts suggest that any healthcare-related announcements in the budget, particularly tax incentives for medical tourism, could boost Apollo Hospitals' stock performance.Successful Minimally Invasive Mastectomy at Apollo Hospitals - 28 Jan, 2025
A 46-year-old breast cancer patient successfully underwent an Endoscopic Mastectomy with Reconstruction at Apollo Proton Cancer Centre, highlighting advancements in breast cancer treatment and the importance of early detection.Apollo Hospitals Gains from KIE Upgrade Amid Challenges - 22 Jan, 2025
Apollo Hospitals is a top Nifty gainer following KIE's upgrade to 'buy.' While the company faces execution risks and ongoing losses from Apollo 24/7, its diversified presence and reduced losses position it for potential upside.Apollo Hospitals Gains After Kotak Upgrade and Partnership - 21 Jan, 2025
Apollo Hospitals shares rose significantly on January 21, 2025, following an upgrade by Kotak Institutional Equities, which raised the target price to ₹8,270. The company also announced a partnership with the University of Leicester to establish a digital health center. Analysts noted reduced execution risks in Apollo's expansion plans, contributing to positive sentiment around the stock.
Insights on Apollo Hospitals Enterprise Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 5.12% to 5.19% in Dec 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, APOLLOHOSP stock has moved up by 0.8%
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 29.33% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 36.1% return, outperforming this stock by 41.0%
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 177.8% return, outperforming this stock by 132.7%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 378.8 Cr → 372.3 Cr (in ₹), with an average decrease of 1.7% per quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 12.80% to 12.77% in Dec 2024 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 45.37% to 45.27% in Dec 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 5.63K Cr → 5.59K Cr (in ₹), with an average decrease of 0.7% per quarter
Apollo Hospitals Enterprise Ltd Financials
Index Inclusions
Apollo Hospitals Enterprise Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 29.33% | 0.00 | |
| Foreign Institutions | 45.27% | ||
| Mutual Funds | 12.77% | ||
| Retail Investors | 5.19% | 1.51 | |
| Others | 7.43% | 0.76 |
Apollo Hospitals Enterprise Ltd Key Indicators
Apollo Hospitals Enterprise Ltd Valuation
Apollo Hospitals Enterprise Ltd in the last 5 years
Lowest (33.30x)
April 1, 2020
Today (70.49x)
February 19, 2025
Industry (92.99x)
February 19, 2025
Highest (341.36x)
June 29, 2021
Apollo Hospitals Enterprise Ltd Earnings and Dividends
Apollo Hospitals Enterprise Ltd Earnings Results
Apollo Hospitals Enterprise Ltd’s net profit jumped 51.77% since last year same period to ₹372.30Cr in the Q3 2024-2025. On a quarterly growth basis, Apollo Hospitals Enterprise Ltd has generated -1.72% fall in its net profits since last 3-months.
Read More about Earnings ResultsApollo Hospitals Enterprise Ltd Dividends February,2025
In the quarter ending December 2024, Apollo Hospitals Enterprise Ltd has declared dividend of ₹9 - translating a dividend yield of 0.30%.
Read More about Dividends
Apollo Hospitals Enterprise Ltd Technicals Summary
Bearish
Neutral
Bullish
Apollo Hospitals Enterprise Ltd is currently in a Bearish trading position according to technical analysis indicators.
Apollo Hospitals Enterprise Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹92,347.85 Cr | 51.34% | 0.65 | ₹917 Cr | ₹19,059 Cr | |
| BUY | ₹99,109.88 Cr | 162.46% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
| BUY | ₹45,531.53 Cr | 57.17% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
| BUY | ₹28,086.33 Cr | 59.09% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| BUY | ₹21,497.46 Cr | 33.89% | 0.58 | ₹336 Cr | ₹2,498 Cr |
About Apollo Hospitals Enterprise Ltd
The company's top products include diagnostics, medical care, pharmacy services, and health insurance. Apollo Hospitals Enterprise Ltd. is also known for its popular brands, such as Apollo Pharmacy, Apollo Cradle, Apollo Spectra, Apollo Diagnostics, and Apollo Clinics.
Share Price: ₹6408.85 per share as on 20 Feb, 2025 01:23 PM
Market Capitalisation: ₹92,347.85Cr as of today
Revenue: ₹5,526.90Cr as on December 2024 (Q4 24)
Net Profit: ₹379.40Cr as on December 2024 (Q4 24)
Listing date: 23 May, 1995
Chairperson Name: Shobana Kamineni
| Organisation | Apollo Hospitals Enterprise Ltd |
| Headquarters | Chennai |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
FAQs on Apollo Hospitals Enterprise Ltd
What is Apollo Hospitals Enterprise Ltd price today?
Apollo Hospitals Enterprise Ltd share price today stands at ₹6408.85, Open: ₹6408, Previous Close: ₹6422.65, High: ₹6469.45, Low: ₹6384.25, 52 Week High: ₹7545.35, 52 Week Low: ₹5693.2.
How to Buy Apollo Hospitals Enterprise Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Apollo Hospitals Enterprise Ltd shares
Is Apollo Hospitals Enterprise Ltd listed on NSE?
Apollo Hospitals Enterprise Ltd is listed on NSE
Is Apollo Hospitals Enterprise Ltd listed on BSE?
Apollo Hospitals Enterprise Ltd is listed on BSE
What are today's High and Low prices of Apollo Hospitals Enterprise Ltd?
- Today's highest price of Apollo Hospitals Enterprise Ltd is ₹6469.45.
- Today's lowest price of Apollo Hospitals Enterprise Ltd is ₹6384.25.
What are today's traded volumes of Apollo Hospitals Enterprise Ltd?
Today's traded volume of Apollo Hospitals Enterprise Ltd(APOLLOHOSP) is 1.95L.
What is today's market capitalisation of Apollo Hospitals Enterprise Ltd?
Today's market capitalisation of Apollo Hospitals Enterprise Ltd(APOLLOHOSP) is ₹92347.85Cr.
What is the 52 Week High and Low Range of Apollo Hospitals Enterprise Ltd?
How much percentage Apollo Hospitals Enterprise Ltd is down from its 52 Week High?
Apollo Hospitals Enterprise Ltd (APOLLOHOSP) share price is ₹6408.85. It is down -15.06% from its 52 Week High price of ₹7545.35
How much percentage Apollo Hospitals Enterprise Ltd is up from its 52 Week low?
Apollo Hospitals Enterprise Ltd (APOLLOHOSP) share price is ₹6408.85. It is up 12.57% from its 52 Week Low price of ₹5693.2
What are the historical returns of Apollo Hospitals Enterprise Ltd?
What is the PE ratio of Apollo Hospitals Enterprise Ltd today?
PE Ratio of Apollo Hospitals Enterprise Ltd is 70.49
PE ratio = Apollo Hospitals Enterprise Ltd Market price per share / Apollo Hospitals Enterprise Ltd Earnings per share